EIRY ROBERTS - 12 Nov 2020 Form 4/A - Amendment Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Chief Medical Officer
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Issuer symbol
NBIX
Transactions as of
12 Nov 2020
Net transactions value
$0
Form type
4/A - Amendment
Filing time
26 Apr 2023, 21:19:16 UTC
Date Of Original Report
16 Nov 2020
Next filing
14 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NBIX Common Stock 13,506 12 Nov 2020 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The initial Form 4 filed on 11/16/2020 inadvertently omitted 29 shares that the reporting person owned directly associated with the purchase of such shares on August 31, 2020 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.